tryptophan has been researched along with Human T-lymphotropic Virus 1 Infection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, S; Inagaki, A; Inagaki, H; Ishida, T; Ito, A; Kinoshita, S; Komatsu, H; Kusumoto, S; Maeda, Y; Masaki, A; Narita, T; Niimi, A; Ogura, H; Ri, M; Suzuki, S; Takino, H; Totani, H; Ueda, R; Utsunomiya, A; Yoshida, T | 1 |
1 other study(ies) available for tryptophan and Human T-lymphotropic Virus 1 Infection
| Article | Year |
|---|---|
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma].
Topics: Aged; Female; HTLV-I Infections; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Multivariate Analysis; Prognosis; Tryptophan | 2015 |